HERB — Humanoid Income Statement
0.000.00%
Consumer DefensivesHighly SpeculativeMicro Cap
- $4.56m
- $4.46m
- $18.59m
Annual income statement for Humanoid, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
R2014 December 31st | 2015 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | PROSPECTUS | PROSPECTUS | PROSPECTUS |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 1,012 | 939 | 12.5 | 14 | 18.6 |
| Cost of Revenue | |||||
| Gross Profit | 143 | 119 | 3.24 | 4.01 | 5.59 |
| Selling / General / Administrative Expenses | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 875 | 826 | 9.81 | 10.6 | 13.7 |
| Operating Profit | 137 | 113 | 2.74 | 3.46 | 4.91 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 137 | 112 | 2.99 | 3.72 | 5.31 |
| Net Income After Taxes | 137 | 112 | 2.99 | 3.72 | 5.31 |
| Net Income Before Extraordinary Items | |||||
| Net Income | 137 | 112 | 2.99 | 3.72 | 5.31 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 137 | 112 | 2.99 | 3.72 | 5.31 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 0.883 | 0.712 | 0.019 | 0.024 | 0.034 |
| Dividends per Share |